Healthcare Outcomes Performance Company (HOPCo) announces the appointment of one of the most esteemed and experienced orthopedic industry executives, David Floyd, to its board of directors.
HOPCo Adds Renowned Industry Vet David Floyd to Board
2 min read Premium comments
Secondary#healthcareoutcomesperformancecompany#davidfloyd
Floyd has spent more than 35 years directing large and small, traditional, and ground-breaking orthopedic companies. Floyd is one of perhaps a handful of currently active executives in orthopedics who led this industry through its most dynamic period of innovation and growth. Not surprisingly, he is a sought after board member for several companies and institutions.
Floyd has led many notable companies. He retired from Stryker Corporation as advisor to the chief executive officer in June 2019. From 2012 to 2018 he was the group president for Stryker Orthopaedics. From 2007 to 2011 he was worldwide president for DePuy Orthopaedics, Inc. He was also president of Abbott Spine Inc. for two years from 2005 to 2007. And before that he led and saved Sulzer Medica as it fought through extraordinary challenges.
HOPCo Chairman and Chief Executive Officer David Jacofsky, M.D., commented on Floyd’s experience saying, “We’re thrilled to welcome David [Floyd] to our board of directors. With more than three decades of experience, he brings leadership and expertise in corporate growth and development, as well as a proven track record in large scale operational integration.”
Dr. Jacofsky continued, “The addition of David [Floyd] to our board complements our mission of stakeholder alignment and musculoskeletal market transformation nationally.”
Floyd expressed excitement about his new position, telling OTW, “I think that HOPCo is one of the most exciting companies in healthcare today. Their vision and ability to improve the quality of care while reducing costs addresses a very compelling need.”
Floyd continued, “This is particularly important today in musculoskeletal care, where the demand for healthcare will continue to rise significantly in the coming years.”
HOPCo is a physician-operated healthcare management company. For the past decade it has used proprietary information technology platforms and standardized clinical protocols to improve the patient care experience. HOPCo’s team of orthopedic and musculoskeletal (MSK) experts focuses on reducing costs and improving outcomes through every aspect of the care process.
For OTW’s recent coverage of HOPCo’s BOD, see “Healthcare Outcomes Performance Company Appoints Alan Hoops to BOD.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.